B Cell Immunophenotyping and Expression Analysis of B Cell Specific Molecules of Patients with Benign Multiple Sclerosis Benign MS Hastalarinin B Hücre İmmünfenotiplemesi ve B Hücresine Özgü Moleküllerin Ekspresyon Analizi
Experimed, cilt.9, sa.3, ss.105-112, 2019 (Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 9 Sayı: 3
- Basım Tarihi: 2019
- Doi Numarası: 10.26650/experimed.2019.19026
- Dergi Adı: Experimed
- Derginin Tarandığı İndeksler: Scopus
- Sayfa Sayıları: ss.105-112
- Anahtar Kelimeler: B cell, Benign Multiple Sclerosis, gene expression, immunophenotyping
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Objective: Multiple Sclerosis (MS) is a progresive and an immune mediated inflammatory central nervous disease. The focus of this study was to determine the possible relationship between B cell immunophenotypes and related gene expressions in the benign MS (BMS) group with disease and cognitive processes. Material and Method: Twenty BMS patients, 16 non-BMS and 28 healthy volunteers were included in the study. Gene expression was performed by real-time PCR (RT-PCR). Immunophenotyping of peripheral B cells was also evaluated by flow cytometry. The relationship between cognitive functions and gene expression levels and B cell subtypes was investigated. Results: It was observed that naïve (CD19+ IgD+CD27-) cells were higher in the BMS group compared to the healthy group (HC), and memory B cells showed opposite changes. Un-switched memory B cells(CD19+IgD+CD27+) were found to be higher in the benign group than in the HC. The expression of BANK and BLNK was found to be lower in both MS groups than in the HC. As a result of neuropsychological examinations and cognitive tests; it was observed that motor processes in BMS were better protected than Non-BMS. Conclusion: These findings support that B cell functions may have molecular and cellular effects, and may lead to regression in inflammation and clinical progression. Molecules showing significant changes in our study may play a role as prognostic biomarkers in MS.